Latest California Healthline Stories
Health Insurance: What If You Could Take It With You?
“Portability” will likely be a buzz word in the health law repeal-and-replace debate, but the concept raises a number of complicated policy issues.
Instead Of Trashing A $600 EpiPen, Some Patients Get A Refill
Epinephrine, the active ingredient in EpiPens, expires after 18 months, and the auto-injector device can’t be refilled or reused. Health professionals are looking for work-arounds they say could save the health system millions.
Advocates Of Flat-Fee Primary Care See Opening In GOP’s Market-Driven Approach
In direct primary care, a monthly fee covers routine care, limiting insurers’ role. But does it really provide better value?
Geriatricians Can Help Aging Patients Navigate Multiple Ailments
Aging adults with complex needs can get special assistance from doctors trained as geriatricians.
Facing Pressure, Insurance Plans Loosen Rules For Covering Addiction Treatment
Aetna will be the third major insurer to remove prior authorization requirements for patients who seek medication-assisted treatments such as Suboxone.
Docs In Northwest Tweak Aid-In-Dying Drugs To Prevent Prolonged Deaths
Some terminal patients, typically high-dose opioid users, who choose to end their lives have taken many hours, even days, to die.
Veteran Teaches Therapists How To Talk About Gun Safety When Suicide’s A Risk
Most veterans who commit suicide do so with a gun, but most therapists don’t understand gun culture. A veteran who has struggled with depression himself now helps bridge that gap by educating mental health professionals.
Five Quick Ways New HHS Secretary Tom Price Could Change The Course Of Health Policy
Tom Price will have significant authority to rewrite the rules for the Affordable Care Act.
Humor may be an antidote for the pain of death for both patients and survivors.
Getting Patients Hooked On An Opioid Overdose Antidote, Then Raising The Price
The device, known as an Evzio, administers just enough naloxone to stabilize someone who has overdosed on drugs. But its manufacturer, Kaleo, may be positioning itself to find profits in a dire health care crisis.